Cargando…

Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines

The ongoing global pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has caused devastating impacts on the public health and the global economy. Rapid viral antigenic evolution has led to the continual generation of new variants....

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Liyan, Lin, Sheng, Chen, Zimin, Cao, Yu, He, Bin, Lu, Guangwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170451/ https://www.ncbi.nlm.nih.gov/pubmed/37164987 http://dx.doi.org/10.1038/s41392-023-01472-x

Ejemplares similares

Expression and Characterization of Recombinant S2 Subunit of SARS-coronavirus S Fusion Protein
por: Yan, Zhe, et al.
Publicado: (2009)

Pan-coronavirus fusion inhibitors as the hope for today and tomorrow
por: Wang, Xinling, et al.
Publicado: (2021)

Griffithsin with A Broad-Spectrum Antiviral Activity by Binding Glycans in Viral Glycoprotein Exhibits Strong Synergistic Effect in Combination with A Pan-Coronavirus Fusion Inhibitor Targeting SARS-CoV-2 Spike S2 Subunit
por: Cai, Yanxing, et al.
Publicado: (2020)

Discovery of New Fusion Inhibitor Peptides against SARS-CoV-2 by Targeting the Spike S2 Subunit
por: Kandeel, Mahmoud, et al.
Publicado: (2021)

SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors
por: Xia, Shuai, et al.
Publicado: (2023)

Crystal structure of SARS-CoV-2 nsp10/nsp16 2′-O-methylase and its implication on antiviral drug design
por: Lin, Sheng, et al.
Publicado: (2020)

Discovery of Highly Potent Small Molecule Pan-Coronavirus Fusion Inhibitors
por: Curreli, Francesca, et al.
Publicado: (2023)

Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation
por: Xia, Shuai, et al.
Publicado: (2021)

Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
por: Xia, Shuai, et al.
Publicado: (2022)

Immunoinformatics-guided designing of epitope-based subunit vaccines against the SARS Coronavirus-2 (SARS-CoV-2)
por: Sarkar, Bishajit, et al.
Publicado: (2020)

RBD-ACE2 binding properties in five SARS-CoV-2 variants of concern with new perspectives in the design of pan-coronavirus peptide inhibitors
por: Yan, Fangfang, et al.
Publicado: (2023)

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
por: Xia, Shuai, et al.
Publicado: (2019)

Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity
por: Zhu, Yuanmei, et al.
Publicado: (2020)

The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
por: Pfefferle, Susanne, et al.
Publicado: (2011)

Novel Inhibitors of 2′-O-Methyltransferase of the SARS-CoV-2 Coronavirus
por: Sulimov, Alexey, et al.
Publicado: (2022)

Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2
por: Kalita, Parismita, et al.
Publicado: (2020)

Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
por: Schneider, William M., et al.
Publicado: (2021)

Characterization of SARS-CoV-2 Omicron spike RBD reveals significantly decreased stability, severe evasion of neutralizing-antibody recognition but unaffected engagement by decoy ACE2 modified for enhanced RBD binding
por: Lin, Sheng, et al.
Publicado: (2022)

Developing pan-β-coronavirus vaccines against emerging SARS-CoV-2 variants of concern
por: Su, Shan, et al.
Publicado: (2022)

A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding
por: Yang, Jing, et al.
Publicado: (2022)

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
por: Shapira, Tirosh, et al.
Publicado: (2022)

Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
por: Xia, Shuai, et al.
Publicado: (2020)

Pan-coronavirus fusion inhibitors possess potent inhibitory activity against HIV-1, HIV-2, and simian immunodeficiency virus
por: Yu, Danwei, et al.
Publicado: (2021)

An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry
por: Lin, Xi, et al.
Publicado: (2022)

Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein
por: Alai, Shweta, et al.
Publicado: (2021)

A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern
por: Lan, Qiaoshuai, et al.
Publicado: (2022)

Crystal structure of the S1 subunit N-terminal domain from DcCoV UAE-HKU23 spike protein
por: Cheng, Yanwei, et al.
Publicado: (2019)

Modal analysis of novel coronavirus (SARS COV-2) using finite element methodology
por: Warsame, Caaisha, et al.
Publicado: (2022)

A viral pan-end RNA element and host complex define a SARS-CoV-2 regulon
por: Khan, Debjit, et al.
Publicado: (2023)

Coronaviruses and SARS-COV-2
por: HASÖKSÜZ, Mustafa, et al.
Publicado: (2020)

The S2 subunit of the spike glycoprotein of bovine coronavirus mediates membrane fusion in insect cells
por: Yoo, Dongwan, et al.
Publicado: (1991)

Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2
por: Sun, Yi-Sheng, et al.
Publicado: (2021)

Crystal structure of Usutu virus envelope protein in the pre-fusion state
por: Chen, Zimin, et al.
Publicado: (2018)

Is PF-00835231 a Pan-SARS-CoV-2 Mpro Inhibitor? A Comparative Study
por: Baig, Mohammad Hassan, et al.
Publicado: (2021)

Development of a bispecific nanobody conjugate broadly neutralizes diverse SARS-CoV-2 variants and structural basis for its broad neutralization
por: Yang, Jing, et al.
Publicado: (2023)

Structural analysis of the coronavirus main protease for the design of pan-variant inhibitors
por: Rungruangmaitree, Runchana, et al.
Publicado: (2023)

SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
por: Vithani, Neha, et al.
Publicado: (2020)

SARS-CoV-2 Nsp16 activation mechanism and a cryptic pocket with pan-coronavirus antiviral potential
por: Vithani, Neha, et al.
Publicado: (2021)

Potential Immunomodulatory Properties of Biologically Active Components of Spices Against SARS-CoV-2 and Pan β-Coronaviruses
por: Sengupta, Sourodip, et al.
Publicado: (2021)

Fusion assays for screening of fusion inhibitors targeting SARS-CoV-2 entry and syncytia formation
por: Chan, Shiu-Wan
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_26limocrelv46qpvtikepnrboc